Pages that link to "Q29618819"
Jump to navigation
Jump to search
The following pages link to Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence (Q29618819):
Displayed 50 items.
- The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes (Q21092132) (← links)
- The impact of environmental factors in severe psychiatric disorders (Q21129355) (← links)
- Kynurenines in CNS disease: regulation by inflammatory cytokines (Q21129356) (← links)
- Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice (Q21133801) (← links)
- Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function (Q21145031) (← links)
- microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder (Q21184126) (← links)
- Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia (Q21203806) (← links)
- Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings (Q21203814) (← links)
- Pharmacology of hallucinations: several mechanisms for one single symptom? (Q21284720) (← links)
- Evidence for X-chromosomal schizophrenia associated with microRNA alterations (Q21562396) (← links)
- Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder (Q22242334) (← links)
- Social brain dysfunctions in schizophrenia: A review of neuroimaging studies (Q22251195) (← links)
- Schizophrenia, “Just the Facts”: What we know in 2008 (Q22251476) (← links)
- Progressive pathology is functionally linked to the domains of language and emotion: meta-analysis of brain structure changes in schizophrenia patients (Q24174832) (← links)
- Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia (Q24293245) (← links)
- d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia (Q24294371) (← links)
- Disrupted-in-schizophrenia 1 (DISC1) plays essential roles in mitochondria in collaboration with Mitofilin (Q24301405) (← links)
- Nucleocytoplasmic Shuttling of Dysbindin-1, a Schizophrenia-related Protein, Regulates Synapsin I Expression (Q24301877) (← links)
- Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin (Q24303507) (← links)
- The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function (Q24308763) (← links)
- Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment (Q24316880) (← links)
- LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia (Q24324059) (← links)
- Generation and characterization of Rgs4 mutant mice (Q24523661) (← links)
- Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain (Q24534089) (← links)
- Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios (Q24538580) (← links)
- Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding protein (Q24543935) (← links)
- p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling (Q24545327) (← links)
- Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease (Q24546782) (← links)
- Identifying gene regulatory networks in schizophrenia (Q24601410) (← links)
- Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex (Q24602550) (← links)
- Replication of association between working memory and Reelin, a potential modifier gene in schizophrenia (Q24606481) (← links)
- Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeutics (Q24608073) (← links)
- Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation (Q24612495) (← links)
- Specific regulation of NRG1 isoform expression by neuronal activity (Q24618674) (← links)
- De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia (Q24621518) (← links)
- Schizophrenia susceptibility gene dysbindin regulates glutamatergic and dopaminergic functions via distinctive mechanisms in Drosophila (Q24625434) (← links)
- Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia (Q24632939) (← links)
- DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms (Q24643052) (← links)
- Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions (Q24643775) (← links)
- Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? (Q24643863) (← links)
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia (Q24646206) (← links)
- Mechanisms of neuregulin action (Q24650665) (← links)
- Rat strain differences in startle gating-disruptive effects of apomorphine occur with both acoustic and visual prepulses (Q24655138) (← links)
- Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes (Q24655969) (← links)
- Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition (Q24681770) (← links)
- Theories of schizophrenia: a genetic-inflammatory-vascular synthesis (Q24800460) (← links)
- No evidence for association between polymorphisms in GRM3 and schizophrenia (Q24810205) (← links)
- Does the CAPON gene confer susceptibility to schizophrenia? (Q24814466) (← links)
- COMT genetic variation confers risk for psychotic and affective disorders: a case control study (Q24816526) (← links)
- Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs (Q26744729) (← links)